TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,104,425
|
3,115,445
|
3,768,139 |
| Earnings before taxes |
-223,774
|
470,517
|
1,150,001 |
| Total assets |
5,833,031
|
5,394,988
|
5,147,044 |
| Current assets |
1,568,283
|
1,784,679
|
2,172,128 |
| Current liabilities |
2,243,333
|
3,246,515
|
2,902,142 |
| Equity capital |
985,485
|
457,701
|
989,590 |
| - share capital |
65,983
|
63,800
|
64,129 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
16.9%
|
8.5%
|
19.2% |
| Turnover per employee |
8,870
|
8,901
|
10,766 |
| Profit as a percentage of turnover |
-7.2%
|
15.1%
|
30.5% |
| Return on assets (ROA) | |||
| Current ratio |
69.9%
|
55.0%
|
74.8% |
| Return on equity (ROE) |
-22.7%
|
102.8%
|
116.2% |
| Change turnover |
-117,592
|
-633,389
|
498,274 |
| Change turnover % |
-4%
|
-17%
|
15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.